Double filtration plasmapheresis combined with rituximab for donor‐specific antibody desensitization in haploidentical haematopoietic stem cell transplantation

L Liu, X Ji, P Zhu, L Yang, J Shi, Y Zhao… - British Journal of …, 2023 - Wiley Online Library
Donor‐specific anti‐HLA antibodies (DSA) are a major cause of engraftment failure in
patients receiving haploidentical haematopoietic stem cell transplantation (Haplo‐HSCT) …
被引用次数：5 相关文章 所有 3 个版本
[PDF] wiley.com

Combination treatment of rituximab and donor platelets infusion to reduce donor‐specific anti‐HLA antibodies for stem cells engraftment in haploidentical …

R Zhang, Y He, D Yang, E Jiang, Q Ma… - Journal of Clinical …, 2020 - Wiley Online Library
Background Donor‐specific anti‐human leukocyte antigen (HLA) antibodies (DSAs) in
recipients is a risk factor for donor stem cell graft failure in haploidentical hematopoietic stem …
被引用次数：22 相关文章 所有 6 个版本
[HTML] sciencedirect.com

[HTML][HTML] Treatment with the combination of Rituximab and intravenous γ globulin is effective in promoting engraftment in donor-specific antibody positive patients …

Y Shen, L Zhang, X Zhang, T Zhang, E Jiang… - … and cellular therapy, 2023 - Elsevier
Donor-specific anti-HLA antibodies (DSAs) are a major cause of engraftment failure in
patients receiving haploidentical stem cell transplantation (HaploSCT). Effective procedures …
被引用次数：3 相关文章 所有 4 个版本
[HTML] sciencedirect.com

Treatment of allosensitized patients receiving allogeneic transplantation

SO Ciurea, MM Al Malki, P Kongtim, J Zou… - Blood …, 2021 - ashpublications.org
Donor-specific anti-HLA antibodies (DSAs) are a major cause of engraftment failure in
patients receiving haploidentical stem cell transplantation (HaploSCT). Effective treatments …
被引用次数：48 相关文章 所有 9 个版本
[HTML] sciencedirect.com

[HTML][HTML] High-Dose immunoglobulin Intervention as an effective and simple strategy for donor specific Anti-HLA antibody desensitization in haploidentical transplant

J Zhu, Q Wang, Y Liu, Y Dong, Z Liang, Y Yin… - International …, 2023 - Elsevier
Donor-specific anti-HLA antibody (DSA) is a significant obstacle to successful haploidentical
hematopoietic stem cell transplantation (haplo-HSCT) and is associated with poor …
被引用次数：4 相关文章 所有 3 个版本
[PDF] frontiersin.org

Management of donor-specific antibodies in haploidentical transplant: Multicenter experience from the Madrid group of hematopoietic transplant

R Bailén, JL Vicario, L Solán… - Frontiers in …, 2021 - frontiersin.org
Background Donor specific antibodies (DSAs) can be responsible for graft failure (GF) in the
setting of mismatched hematopoietic stem cell transplantation (HSCT). The aim of our study …
被引用次数：18 相关文章 所有 10 个版本
[HTML] nih.gov

Pretransplant desensitization of donor-specific anti-HLA antibodies with plasmapheresis and immunoglobulin produces equivalent outcomes to patients with no donor …

HC Cochran, MJ Slade, C Liu, F Gao… - Leukemia & …, 2024 - Taylor & Francis
Haploidentical hematopoietic cell transplants (haplo-HCT) with donor-specific anti-HLA
antibodies (DSAs) are associated with high rates of primary graft failure and poor overall …
被引用次数：2 相关文章 所有 5 个版本

Successful desensitization of high level donor-specific anti-HLA antibody in patients with hematological diseases receiving haploidentical allografts

X Zheng, H Yan, D Han, L Ding, L Zhu, J Liu, M Xue… - Annals of …, 2022 - Springer
Donor-specific anti-human leukocyte antigen (HLA) antibody (DSA) is associated with a
higher incidence of graft failure and mortality in HLA-mismatched allograft settings …
被引用次数：4 相关文章 所有 5 个版本
[HTML] nih.gov

[HTML][HTML] Donor specific anti-HLA antibodies in hematopoietic stem cell transplantation. Single center prospective evaluation and desensitization strategies employed

U La Rocca, MP Perrone, A Piciocchi… - Blood …, 2023 - pmc.ncbi.nlm.nih.gov
Background In the setting of mismatched-hematopoietic stem cells transplantation, the
detection of antibodies directed against donor-specific HLA allele (s) or antigen (s)(DSA) …
被引用次数：4 相关文章 所有 7 个版本
[PDF] academia.edu

Desensitization with plasma exchange in a patient with human leukocyte antigen donor‐specific antibodies before T‐cell–replete haploidentical transplantation

S Bramanti, A Nocco, E Mauro, G Milone… - …, 2016 - Wiley Online Library
BACKGROUND The presence of human leukocyte antigen donor‐specific antibodies
(DSAs) increases the risk of graft failure in T‐cell–replete haploidentical hematopoietic stem …
被引用次数：16 相关文章 所有 9 个版本